Texas Eye and Cataract became the first ophthalmology practice in North Texas to perform a procedure for the new DURYSTA™ bimatoprost implant.
DURYSTA is believed to lower IOP in humans by increasing the outflow of aqueous humor through both the trabecular meshwork (conventional) and uveoscleral routes (unconventional).
Remaining on the cutting edge of eye care innovation, Texas Eye and Cataract became the first ophthalmology practice in North Texas to perform a proce ...